aXichem AB (publ), which develops and markets natural analogue industrial chemicals, updates the company's goals for 2022 and intensifies work to establish the natural analogue product, phenylcapsaicin, as a salmonella-inhibiting ingredient in animal feed, as a health-promoting component in dietary supplements and as a bioenhancer. aXichem thus adds to the objectives announced in the report for the third quarter of 2021. In 2022, aXichem aims to, through a framework agreement with a major animal feed producer in Europe, create a stable position for phenylcapsaicin as a standard ingredient in animal feed. Furthermore, the company will commercially strengthen the approval according to Novel Food, which the product already has in the EU, by applying for "Feed Additive" approval in the EU, and by obtaining “Feed Additive” approval in Brazil.
The new additional objectives for the company will also be commented on during the presentation that the company will hold at the Redeye Investor Forum in Malmö, Sweden, later today.
– The overall goal, to establish our product in the selected segments in the EU, South America and the USA in such a way that production capacity and logistics give the customer a positive experience, remains unchanged. Together with our distributor CHR. Olesen, we have ongoing positive and constructive discussions with several major feed producers, which we believe can result in an agreement next year and give the product a strong position in the market in the long term. By adding Feed Additive to our strong data from tests and our Novel Food, we have a complete product in all respects, says Torsten Helsing, CEO of aXichem.
In the past year, aXichem has conducted a number of studies and tests on phenylcapsaicin to produce data that support the safety and efficacy of the products aXiphen® feed and aXivite®. Both of these products are dietary supplements that promote intestinal health - aXiphen® feed as an ingredient in animal feed and aXivite® as a dietary supplement for weight control for humans. Furthermore, new tests where the product has been evaluated as a bioenhancer, i.e. as an enhancer of another ingredient in, for example, a dietary supplement, have shown that phenylcapsaicin has unique and commercially interesting properties.
– In 2021, we have seen many new consumer products in Europe and the US launched, with aXivite as the active ingredient. The goal for next year is to continue this fine development for the product segment in dietary supplements that promotes intestinal health and weight control. In this area, we also position phenylcapsaicin as a bioenhancer in products that are not classified as drugs. An interesting area with great potential that we will continue to work on in 2022, says Lucas Altepost, Deputy CEO and VP Marketing & Sales at aXichem.
More about aXiphen aXiphen is a natural analogue substance, a synthetically produced and patented capsaicin. As aXiphen is synthetically produced, the substance has a number of advantages over natural capsaicin. The crucial difference is that natural capsaicin is extracted from chili and therefore has varying quality and thus rarely reaches a concentration above 85 percent. aXiphen has at least 97 percent concentration and predictable properties. One of the great industrial advantages of aXiphen is that aXichem in production can control its water and fat solubility, something that is extremely important when using the substance in different types of end products. aXiphen is approved according to GRAS food in the USA and according to Novel Food in Europe.
This information is such that aXichem AB is obliged to publish in accordance with the EU Market Abuse Regulation. The information was submitted, through the care of the contact person below, for publication on December 9, 2021 at 08:30 AM CET.
